ChartMill assigns a Buy % Consensus number of 83% to BRNS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-13 | Barclays | Maintains | Overweight |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
The consensus rating for BARINTHUS BIOTHERAPEUTICS PL (BRNS) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering BARINTHUS BIOTHERAPEUTICS PL (BRNS) is 8.